Arcutis Biotherapeutics, Inc. (ARQT) on GreekSoup https://greeksoup.ai/stocks/us/arqt/ Every dated entry in the public record on Arcutis Biotherapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Arcutis Biotherapeutics, Inc.: Form 144, Larry Todd Edwards plans to sell 60,376 shares worth $2.0 million around 20 October 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-10-20:484dbe5bb2Tue, 20 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Welgus Howard G. (Director) sold 4,728 shares (under a trading plan set in advance) at $26.93 on 15 October 2026, $127,325https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-10-19:363e0df251Mon, 19 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Howard Welgus plans to sell 4,728 shares worth $127,325 around 15 October 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-10-15:c9cd05dcbdThu, 15 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: short interest 20,485,453 shares at the 15 October 2026 settlement, 9.78 days to coverhttps://greeksoup.ai/stocks/us/arqt/short-interest/us:ARQT:short-interest:2026-10-15:7e7b8a4919Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Schedule 13G/A filed by BlackRock, Inc., 14.1% of the classhttps://greeksoup.ai/stocks/us/arqt/holders/us:ARQT:schedule-13:2026-10-05:c392c0ca6aMon, 05 Oct 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: short interest 21,688,918 shares at the 30 September 2026 settlement, 4.83 days to coverhttps://greeksoup.ai/stocks/us/arqt/short-interest/us:ARQT:short-interest:2026-09-30:4f5f0a3380Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Matsuda Masaru (See Remarks) sold 3,674 shares (under a trading plan set in advance) at $25.00 on 16 September 2026, $91,853https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-09-18:1aaa72a624Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Welgus Howard G. (Director) sold 4,730 shares (under a trading plan set in advance) at $24.18 on 15 September 2026, $114,371https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-09-17:876f7c414dThu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Larry Todd Edwards plans to sell 341,980 shares worth $8.5 million around 16 September 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-09-16:524b7c2dc9Wed, 16 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Howard Welgus plans to sell 4,730 shares worth $114,371 around 15 September 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-09-15:17320ab1c0Tue, 15 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: short interest 18,458,091 shares at the 15 September 2026 settlement, 8.54 days to coverhttps://greeksoup.ai/stocks/us/arqt/short-interest/us:ARQT:short-interest:2026-09-15:cfb775704cTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Matsuda Masaru (See Remarks) sold 9,989 shares (under a trading plan set in advance) at $25.03 on 8 September 2026, $249,986https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-09-10:b784e73a21Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Masaru Matsuda plans to sell 13,663 shares worth $341,933 around 8 September 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-09-08:7bda07515bTue, 08 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: short interest 16,557,048 shares at the 31 August 2026 settlement, 9.41 days to coverhttps://greeksoup.ai/stocks/us/arqt/short-interest/us:ARQT:short-interest:2026-08-31:5684071f5cMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Curran Terrie (Director) sold 11,148 shares at $25.03 on 27 August 2026, $279,028https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-08-28:944637ad7dFri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Curran Terrie (Director) sold 27,052 shares at $25.03 on 27 August 2026, $677,095https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-08-28:20a6f5e724Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Terrie Curran plans to sell 38,200 shares worth $956,125 around 27 August 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-08-27:3eb0db1f71Thu, 27 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Curran Terrie (Director) sold 1,072 shares at $26.04 on 20 August 2026, $27,912https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-08-24:4eaeeb4602Mon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Burnett Patrick (See Remarks) sold 1,697 shares at $27.00 on 19 August 2026, $45,819https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-08-21:6501885c50Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Terrie Curran plans to sell 1,072 shares worth $27,912 around 20 August 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-08-20:b7a4f57534Thu, 20 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Patrick Burnett plans to sell 1,697 shares worth $45,819 around 19 August 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-08-19:c3dc00e48bWed, 19 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Welgus Howard G. (Director) sold 4,730 shares (under a trading plan set in advance) at $26.18 on 17 August 2026, $123,835https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-08-19:d196e6d004Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Howard Welgus plans to sell 4,730 shares worth $123,835 around 17 August 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-08-17:cb040b41dbMon, 17 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Schedule 13G filed by Polar Capital Holdings Plc, 5.3% of the classhttps://greeksoup.ai/stocks/us/arqt/holders/us:ARQT:schedule-13:2026-08-14:14012d56f5Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: short interest 14,717,905 shares at the 14 August 2026 settlement, 8.04 days to coverhttps://greeksoup.ai/stocks/us/arqt/short-interest/us:ARQT:short-interest:2026-08-14:4a62321e64Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Burnett Patrick (See Remarks) sold 6,700 shares at $26.08 on 12 August 2026, $174,767https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-08-13:77ee4c909dThu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Burnett Patrick (See Remarks) sold 8,300 shares at $26.52 on 11 August 2026, $220,129https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-08-13:73b79e5c75Thu, 13 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Patrick Burnett plans to sell 15,000 shares worth $397,824 around 11 August 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-08-11:11f616957aTue, 11 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Schedule 13G filed by STATE STREET CORPORATION, 4.7% of the classhttps://greeksoup.ai/stocks/us/arqt/holders/us:ARQT:schedule-13:2026-08-07:fcc48c2708Fri, 07 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc. Q2 FY2026 results: revenue $130 million, net income $15 millionhttps://greeksoup.ai/stocks/us/arqt/results/fy2026-q2/us:ARQT:result:2026-08-05:cad6e821daWed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/arqt/filings/us:ARQT:filing:2026-08-05:53a6e8ad27Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc. filed 8-K: results of operations, officer or director changehttps://greeksoup.ai/stocks/us/arqt/filings/us:ARQT:filing:2026-08-05:c895239306Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Burnett Patrick (See Remarks) sold 955 shares (under a trading plan set in advance) at $26.12 on 3 August 2026, $24,942https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-08-05:7ae466cc44Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Matsuda Masaru (See Remarks) sold 1,230 shares (under a trading plan set in advance) at $26.12 on 3 August 2026, $32,124https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-08-05:47d2791a72Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Watanabe Todd (See Remarks) sold 4,375 shares (under a trading plan set in advance) at $26.12 on 3 August 2026, $114,261https://greeksoup.ai/stocks/us/arqt/insiders/us:ARQT:insider:2026-08-05:f8d3e14abfWed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Patrick Burnett plans to sell 955 shares worth $24,942 around 3 August 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-08-03:56eed06338Mon, 03 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Matsuda Masaru plans to sell 1,230 shares worth $32,124 around 3 August 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-08-03:c94110aa41Mon, 03 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: Form 144, Todd Frank Watanabe plans to sell 4,375 shares worth $114,261 around 3 August 2026https://greeksoup.ai/stocks/us/arqt/planned-sales/us:ARQT:planned-sale:2026-08-03:476e498ad8Mon, 03 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcutis Biotherapeutics, Inc.: short interest 12,686,384 shares at the 31 July 2026 settlement, 10.74 days to coverhttps://greeksoup.ai/stocks/us/arqt/short-interest/us:ARQT:short-interest:2026-07-31:57da1998d8Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>